Agenda of the PRAC meeting 4-7 May 2026
Submitted by Anonymous (not verified) on 5 May 2026 - 15:43
Agenda of the PRAC meeting 4-7 May 2026
European Medicines Agency’s data protection notice for the management of traineeships at EMA
Submitted by Anonymous (not verified) on 5 May 2026 - 15:21
European Medicines Agency’s data protection notice for the management of traineeships at EMA
Minutes of the CAT meeting 18-20 March 2026
Submitted by Anonymous (not verified) on 5 May 2026 - 15:19
Minutes of the CAT meeting 18-20 March 2026
Minutes of the COMP meeting 17-18 March 2026
Submitted by Anonymous (not verified) on 5 May 2026 - 15:14
Minutes of the COMP meeting 17-18 March 2026
Questions and answers on implementation of Ph.Eur. Medicinal Product Monographs (MPM)
Submitted by Anonymous (not verified) on 5 May 2026 - 15:02
Questions and answers on implementation of Ph.Eur. Medicinal Product Monographs (MPM)
Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Date of authorisation: 27/04/2026, Status: Authorised
Submitted by Anonymous (not verified) on 5 May 2026 - 14:24
Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Date of authorisation: 27/04/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 35, Status: Authorised
Submitted by Anonymous (not verified) on 5 May 2026 - 13:24
Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 35, Status: Authorised
QRD veterinary combined label-leaflet template v.9.1
Submitted by Anonymous (not verified) on 5 May 2026 - 12:00
QRD veterinary combined label-leaflet template v.9.1
Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 7, Status: Withdrawn
Submitted by Anonymous (not verified) on 5 May 2026 - 10:27
Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 7, Status: Withdrawn
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 10, Status: Withdrawn
Submitted by Anonymous (not verified) on 5 May 2026 - 10:17
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 10, Status: Withdrawn